1015 Capital Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
1015 Capital Partners's WST Position: Q3 2026 in Review
1015 Capital Partners sold out of West Pharmaceutical (WST) in Q3 2026, closing a stake of 2 shares — an estimated $718 sold.
1015 Capital Partners first reported a position in WST in Q4 2025 and held it in 3 quarters. The position peaked at $718 in Q2 2026. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- 1015 Capital Partners reported no remaining West Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- 1015 Capital Partners sold 2 West Pharmaceutical shares in Q3 2026, an estimated $718.
- 1015 Capital Partners first reported a position in West Pharmaceutical in Q4 2025 and held it in 3 quarters.
- 1015 Capital Partners's West Pharmaceutical position peaked at $718 in Q2 2026.
- 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on 1015 Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.